Back to Search
SHAI KONNAR ANSELL, MD
MD
General Practice Physician
NPI: 1851856140Individual
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
0101270267(VA)
Research & Publications (20)
Modulating the therapeutic activity of nanoparticle delivered paclitaxel by manipulating the hydrophobicity of prodrug conjugates.
PMID 18465845·J Med Chem·2008
7-preclinical
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
PMID 19648970·Bone Marrow Transplant·2010
3-trial
Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma.
PMID 19383901·Cancer Res·2009
8-other
Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.
PMID 19577568·Gastroenterology·2009
8-other
Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells.
PMID 19671921·Blood·2009
7-preclinical
Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma.
PMID 19509224·Cancer Res·2009
8-other
Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2.
PMID 19641186·Blood·2009
8-other
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.
PMID 19597183·Blood·2009
8-other
A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation.
PMID 19321861·Blood·2009
8-other
Cytokines in the microenvironment of Waldenström's macroglobulinemia.
PMID 19362970·Clin Lymphoma Myeloma·2009
6-review
Serum BLyS levels increase after rituximab as initial therapy in patients with follicular Grade 1 non-Hodgkin lymphoma.
PMID 19051265·Am J Hematol·2009
4-observational
Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.
PMID 19344414·Br J Haematol·2009
8-other
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
PMID 18633131·Blood·2008
8-other
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
PMID 18990758·Cancer Epidemiol Biomarkers Prev·2008
8-other
Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
PMID 18699848·Br J Haematol·2008
8-other
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative.
PMID 18828972·Mayo Clin Proc·2008
4-observational
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years.
PMID 18798106·Leuk Lymphoma·2008
8-other
A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma.
PMID 18927313·Clin Cancer Res·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1721 Admiral Taussig Blvd
Norfolk, VA 23511 - Phone
- (405) 535-7685
Quick Facts
- NPI
- 1851856140
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile